CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells

D. Parolini, M. Meregalli, M. Belicchi, P. Razini, R. Lopa, B. Del Carlo, A. Farini, S. Maciotta, N. Bresolin, L. Porretti, M. Pellegrino, Y. Torrente

Research output: Contribution to journalArticle

Abstract

Among the heterogeneous population of circulating hematopoietic and endothelial progenitors, we identified a subpopulation of CD133+ cells displaying myogenic properties. Unexpectedly, we observed the expression of the B-cell marker CD20 in blood-derived CD133+ stem cells. The CD20 antigen plays a role in the modulation of intracellular calcium homeostasis through signaling pathways activation. Several observations suggest that an increase in intracellular calcium concentration ([Ca2+]i) could be involved in the etiology of the Duchenne muscular dystrophy (DMD). Here, we show that a CD20-related signaling pathway able to induce an increase in [Ca2+]i is differently activated after brain derived neurotrophic factor (BDNF) stimulation of normal and dystrophic blood-derived CD133+ stem cells, supporting the assumption of a "CD20-related calcium impairment" affecting dystrophic cells. Presented findings represent the starting point toward the expansion of knowledge on pathways involved in the pathology of DMD and in the behavior of dystrophic blood-derived CD133+ stem cells.

Original languageEnglish
Pages (from-to)697-710
Number of pages14
JournalCellular and Molecular Life Sciences
Volume66
Issue number4
DOIs
Publication statusPublished - Feb 2009

Fingerprint

Stem Cells
Duchenne Muscular Dystrophy
Calcium
CD20 Antigens
Brain-Derived Neurotrophic Factor
Homeostasis
B-Lymphocytes
Pathology
Population

Keywords

  • Brain derived neurotrophic factor (BDNF)
  • Ca
  • CD133
  • CD20
  • Circulating stem cells
  • Duchenne muscular dystrophy (DMD)

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Molecular Medicine
  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells. / Parolini, D.; Meregalli, M.; Belicchi, M.; Razini, P.; Lopa, R.; Del Carlo, B.; Farini, A.; Maciotta, S.; Bresolin, N.; Porretti, L.; Pellegrino, M.; Torrente, Y.

In: Cellular and Molecular Life Sciences, Vol. 66, No. 4, 02.2009, p. 697-710.

Research output: Contribution to journalArticle

Parolini, D. ; Meregalli, M. ; Belicchi, M. ; Razini, P. ; Lopa, R. ; Del Carlo, B. ; Farini, A. ; Maciotta, S. ; Bresolin, N. ; Porretti, L. ; Pellegrino, M. ; Torrente, Y. / CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells. In: Cellular and Molecular Life Sciences. 2009 ; Vol. 66, No. 4. pp. 697-710.
@article{4849e8dddf5e42c2bdd792f53554abc4,
title = "CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells",
abstract = "Among the heterogeneous population of circulating hematopoietic and endothelial progenitors, we identified a subpopulation of CD133+ cells displaying myogenic properties. Unexpectedly, we observed the expression of the B-cell marker CD20 in blood-derived CD133+ stem cells. The CD20 antigen plays a role in the modulation of intracellular calcium homeostasis through signaling pathways activation. Several observations suggest that an increase in intracellular calcium concentration ([Ca2+]i) could be involved in the etiology of the Duchenne muscular dystrophy (DMD). Here, we show that a CD20-related signaling pathway able to induce an increase in [Ca2+]i is differently activated after brain derived neurotrophic factor (BDNF) stimulation of normal and dystrophic blood-derived CD133+ stem cells, supporting the assumption of a {"}CD20-related calcium impairment{"} affecting dystrophic cells. Presented findings represent the starting point toward the expansion of knowledge on pathways involved in the pathology of DMD and in the behavior of dystrophic blood-derived CD133+ stem cells.",
keywords = "Brain derived neurotrophic factor (BDNF), Ca, CD133, CD20, Circulating stem cells, Duchenne muscular dystrophy (DMD)",
author = "D. Parolini and M. Meregalli and M. Belicchi and P. Razini and R. Lopa and {Del Carlo}, B. and A. Farini and S. Maciotta and N. Bresolin and L. Porretti and M. Pellegrino and Y. Torrente",
year = "2009",
month = "2",
doi = "10.1007/s00018-009-8652-2",
language = "English",
volume = "66",
pages = "697--710",
journal = "Cellular and Molecular Life Sciences",
issn = "1420-682X",
publisher = "Birkhauser Verlag Basel",
number = "4",

}

TY - JOUR

T1 - CD20-related signaling pathway is differently activated in normal and dystrophic circulating CD133+ stem cells

AU - Parolini, D.

AU - Meregalli, M.

AU - Belicchi, M.

AU - Razini, P.

AU - Lopa, R.

AU - Del Carlo, B.

AU - Farini, A.

AU - Maciotta, S.

AU - Bresolin, N.

AU - Porretti, L.

AU - Pellegrino, M.

AU - Torrente, Y.

PY - 2009/2

Y1 - 2009/2

N2 - Among the heterogeneous population of circulating hematopoietic and endothelial progenitors, we identified a subpopulation of CD133+ cells displaying myogenic properties. Unexpectedly, we observed the expression of the B-cell marker CD20 in blood-derived CD133+ stem cells. The CD20 antigen plays a role in the modulation of intracellular calcium homeostasis through signaling pathways activation. Several observations suggest that an increase in intracellular calcium concentration ([Ca2+]i) could be involved in the etiology of the Duchenne muscular dystrophy (DMD). Here, we show that a CD20-related signaling pathway able to induce an increase in [Ca2+]i is differently activated after brain derived neurotrophic factor (BDNF) stimulation of normal and dystrophic blood-derived CD133+ stem cells, supporting the assumption of a "CD20-related calcium impairment" affecting dystrophic cells. Presented findings represent the starting point toward the expansion of knowledge on pathways involved in the pathology of DMD and in the behavior of dystrophic blood-derived CD133+ stem cells.

AB - Among the heterogeneous population of circulating hematopoietic and endothelial progenitors, we identified a subpopulation of CD133+ cells displaying myogenic properties. Unexpectedly, we observed the expression of the B-cell marker CD20 in blood-derived CD133+ stem cells. The CD20 antigen plays a role in the modulation of intracellular calcium homeostasis through signaling pathways activation. Several observations suggest that an increase in intracellular calcium concentration ([Ca2+]i) could be involved in the etiology of the Duchenne muscular dystrophy (DMD). Here, we show that a CD20-related signaling pathway able to induce an increase in [Ca2+]i is differently activated after brain derived neurotrophic factor (BDNF) stimulation of normal and dystrophic blood-derived CD133+ stem cells, supporting the assumption of a "CD20-related calcium impairment" affecting dystrophic cells. Presented findings represent the starting point toward the expansion of knowledge on pathways involved in the pathology of DMD and in the behavior of dystrophic blood-derived CD133+ stem cells.

KW - Brain derived neurotrophic factor (BDNF)

KW - Ca

KW - CD133

KW - CD20

KW - Circulating stem cells

KW - Duchenne muscular dystrophy (DMD)

UR - http://www.scopus.com/inward/record.url?scp=60149091558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60149091558&partnerID=8YFLogxK

U2 - 10.1007/s00018-009-8652-2

DO - 10.1007/s00018-009-8652-2

M3 - Article

C2 - 19153665

AN - SCOPUS:60149091558

VL - 66

SP - 697

EP - 710

JO - Cellular and Molecular Life Sciences

JF - Cellular and Molecular Life Sciences

SN - 1420-682X

IS - 4

ER -